Indication

Anaerobic lung abscess

An anaerobic lung abscess is a localized, cavitary pulmonary infection characterized by microbial liquefactive necrosis of the lung parenchyma, driven predominantly by anaerobic oral commensals such as *Peptostreptococcus*, *Fusobacterium*, and *Prevotella* species. Read more about Anaerobic lung abscess

80 drugs 59 manufacturers

Advertisement

Drugs that treat it

Common Anaerobic lung abscess therapies.

Showing 1–9 of 80 drugs

CLINDAMYCIN HCL

CLINDAMYCIN SYSTEMIC·SEPSIS CAUSED BY ANAEROBIC BACTERIA·+19
Major Pharamceuticals
Filter & compare in the drug finder →Opens the drug finder with Anaerobic lung abscess preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Anaerobic lung abscess.

An anaerobic lung abscess is a localized, cavitary pulmonary infection characterized by microbial liquefactive necrosis of the lung parenchyma, driven predominantly by anaerobic oral commensals such as *Peptostreptococcus*, *Fusobacterium*, and *Prevotella* species.

This condition most frequently arises in adult populations predisposed to microaspiration of oropharyngeal secretions, particularly individuals with severe periodontal disease, impaired cough reflexes, dysphagia, or altered consciousness due to alcohol misuse or neurologic impairment.

Pathophysiologically, the aspirated anaerobes incite intense focal pneumonitis and tissue destruction, progressing over days to weeks into a thick-walled necrotic cavity that classically demonstrates an air-fluid level on thoracic imaging and produces putrid, foul-smelling sputum.

Personalize your experience

Follow Anaerobic lung abscess and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it